PlusVitech has been selected for MassChallenge US Early Cohort 2023.
The MassChallenge US Early Stage accelerator is a 3-month mentorship-based programme that provides intensive support, guidance, tools and connectivity to the MassChallenge community to drive traction for startups. The programme is industry independent and focuses on supporting approximately 200 startups per cohort that range in stage from those currently engaged in customer discovery work to validation of a technology or service.
Being part of this programme is an extraordinary experience, and we owe a huge thank you to Chaya Pomeranz-Sherman, the programme director, and the entire MassChallenge team for their incredible support.
Through invaluable coaching and mentoring, we have not only grown as a team, but we have also moved closer to achieving our goals. This programme plays a pivotal role in helping us secure investment and has been instrumental in advancing our approval process for the innovative lung cancer treatment we are developing.
PlusVitech
